title: Optimizing TNFα antagonist therapy in patients with spondyloarthritis: why and how?
authors: Daniel
authors: D
authors: Wendling
authors: Clément
authors: C
authors: Prati
authors: Philippe
authors: P
authors: Goupille
authors: Denis
authors: D
authors: Mulleman
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D057915:Drug Substitution; D006801:Humans; D017410:Practice Guidelines as Topic; D011379:Prognosis; D013167:Spondylitis, Ankylosing / Q000175:diagnosis / Q000188:drug therapy*; D017211:Treatment Failure; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha